Skip to main content

Table 2 Summary of patient disposition [18].

From: The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)

Patient Status Number of patients (%)
  Aripiprazole All SOC Total
Enrolled    593
Randomised 284 271 555
Discontinuation from treatment phase 120 (42.3) 105 (38.7) 225 (40.5)
Lack of efficacy 33 (11.6) 20 (7.4) 53 (9.5)
Adverse event 57 (20.1) 43 (15.9) 100 (18.0)
Withdrew consent 8 (2.8) 18 (6.6) 26 (4.7)
Death 1 (0.4) 2 (0.7) 3 (0.5)
Lost to follow-up 6 (2.1) 6 (2.2) 12 (2.2)
Poor or non-compliance 10 (3.5) 10 (3.7) 20 (3.6)
Pregnancy 2 (0.7) 2 (0.7) 4 (0.7)
Non longer meets study criteria 2 (0.7) 3 (1.1) 5 (0.9)
Other 1 (0.4) 1 (0.4) 2 (0.4)
Completed treatment phase 164 (57.7) 166 (61.3) 330 (59.5)
Randomised, but did not receive study medication 2 5 7